Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
The console was released in Japan on November 1, 2008, and worldwide beginning in April 2009
doi: 10.1007/s13205-012-0061-9 152
30 days (reconstituted) Mechanism Classification Primary Mechanism: NNMT (Nicotinamide N-methyltransferase) Inhibitor Target Enzyme: Nicotinamide N-methyltransferase Cellular Effect: Increases intracellular NAD+ and SAM levels Metabolic Pathway: NAD+ salvage pathway modulation Selectivity: Highly selective for NNMT (no cross-reactivity with related enzymes) Pharmacological Properties Route of Administration: Subcutaneous injection Bioavailability: High (subcutaneous)
It pushed my growth hormone up by ~8x
The primary mechanism involves copper delivery to dermal tissues where this essential cofactor supports numerous enzymatic processes including collagen synthesis, elastin production, glycosaminoglycan formation, and antioxidant enzyme activation
